Home>News Center>China

Human trials for SARS vaccine
(China Daily)
Updated: 2004-02-04 23:06

Chinese scientists will begin selecting volunteers for clinical tests of a SARS (severe acute respiratory syndrome) vaccine.

The State Drug Administration (SDA) authorized Beijing-based Sinovac Biotech Co Ltd to select volunteers for its vaccine research, Cao Wenzhuang, director of the Department of Drug Regulation, told China Daily yesterday.

The SDA sets only the standard number of volunteers needed for the first clinical test of the vaccine, Cao said.

However, Cao's department does not select the actual volunteers.

The SARS vaccine created by the Sinovac Biotech Co Ltd and two other research institutes -- including Chinese Centre for Disease Control and Prevention -- got the go ahead for further clinical tests late last year.

Sinovac spokespeople did not confirm yesterday how many volunteers are needed or if the process has started.

The research team has drawn up an implementation plan for the clinical research of a SARS vaccine.

Cao said his department has approved only one institute, which is Sinovac.

The first phase of the testing will last for three months in either Beijing, South China's Guangdong Province or neighbouring Guangxi Zhuang Autonomous Region.

The volunteers will comprise 15 men and 15 women between the ages of 18 and 40. They will go through medical examinations and clinical observations.

  Today's Top News     Top China News

Greenspan: Free floatation of the yuan could be risky



Political advisers pledge to better people's life



Jam-proof satellite going up next year



More and more women saying no to abusers



Bush, Kerry open battle for White House



NASA: Mars had enough water for life


  Hunan lifts job ban on HBV carriers
  Political advisers pledge to better people's life
  More and more women saying no to abusers
  Jam-proof satellite going up next year
  Traffic flow given top priority
  People's congresses explained
  Go to Another Section  
  Story Tools  
  Related Stories  
Antibody could block SARS infection - study
30 volunteers to receive SARS vaccine
WHO: Investigate into sources of SARS cases
China announces a new confirmed SARS case
  News Talk  
  When hypocrisy teachers complain about hypocrisy students